CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to test if treatment with tralokinumab is safe and effectful to treat moderate-to-severe atopic hand eczema. Th...
Phase 3
Seoul, South Korea and 69 other locations
The study is designed to evaluate the long-term safety and efficacy of GSK1070806 in participants with moderate-to severe atopic dermatitis, who have...
Phase 2
Seoul, Korea, Republic of and 52 other locations
This study is parallel group, placebo-controlled dose-ranging study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of GSK10...
Phase 2
Seoul, Korea, Republic of and 91 other locations
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Phase 3
Seoul, South Korea and 540 other locations
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab with/without Topical Corticosteroid Treatment in Participants w...
Phase 3
Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of and 45 other locations
assigned dose or be reassigned to a different dose based on their Eczema Area and Severity Index (EASI) response. Approximately 300 adult pa...
Phase 3
Seoul, Seoul Teugbyeolsi, Korea, Republic of and 95 other locations
A Multicenter, Randomized, Single-Blind, Phase Ⅱ Clinical Trial and Open Label Long-term Observation Study of ADSTEM Inj. to Evaluate the Safety and...
Phase 2
Seoul, Seoulteukbyeolsi, Korea, Republic of and 5 other locations
The primary objective of this study is to assess successful self-administration of rocatinlimab subcutaneously using devices for injection.
Phase 3
Seoul, Korea, Republic of and 46 other locations
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Phase 3
Seoul, South Korea and 556 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...
Phase 3
Seoul, Korea, Republic of and 194 other locations
Clinical trials
Research sites
Resources
Legal